Malignant pleural effusion and Appetite - decreased
Summary:
Appetite - decreased is found among people with Malignant pleural effusion, especially for people who are female, 60+ old.
The study analyzes which people have Appetite - decreased with Malignant pleural effusion. It is created by eHealthMe based on reports of 11 people who have Malignant pleural effusion from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Malignant pleural effusion?
Malignant pleural effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung) is found to be associated with 357 drugs and 448 conditions by eHealthMe. Check the latest studies of Malignant pleural effusion.
What is Appetite - decreased?
Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,554 drugs and 4,589 conditions by eHealthMe. Check the latest studies of Appetite - decreased.
11 people who have Malignant Pleural Effusion and Appetite - Decreased are studied.

Gender of people who have Malignant Pleural Effusion and experienced Appetite - Decreased *:
- female: 83.33 %
- male: 16.67 %
Age of people who have Malignant Pleural Effusion and experienced Appetite - Decreased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 20 %
- 40-49: 0.0 %
- 50-59: 20 %
- 60+: 60 %
Common co-existing conditions for these people *:
- Lung Cancer - Non-Small Cell (lung cancer): 4 people, 36.36%
- High Blood Pressure: 2 people, 18.18%
- Stomatitis (inflammation of mucous membrane of mouth): 1 person, 9.09%
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 1 person, 9.09%
- Cancer Pain: 1 person, 9.09%
- Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 9.09%
- Diarrhea: 1 person, 9.09%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 9.09%
- Erysipelas (bacterial skin infection): 1 person, 9.09%
- Ewing's Sarcoma (malignant small, round, blue cell tumour): 1 person, 9.09%
Common drugs taken by these people *:
- Pemetrexed: 3 people, 27.27%
- Zosyn: 2 people, 18.18%
- Iressa: 1 person, 9.09%
- Aloxi: 1 person, 9.09%
- Carboplatin: 1 person, 9.09%
- Decadron: 1 person, 9.09%
- Docetaxel: 1 person, 9.09%
- Emend: 1 person, 9.09%
- Flagyl: 1 person, 9.09%
- Ibrance: 1 person, 9.09%
Common symptoms for these people *:
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 45.45%
- High Blood Pressure: 5 people, 45.45%
- Thrombocytopenia (decrease of platelets in blood): 4 people, 36.36%
- Anaemia (lack of blood): 4 people, 36.36%
- Infection: 4 people, 36.36%
- Leukopenia (less number of white blood cells in blood): 3 people, 27.27%
- Liver Injury: 3 people, 27.27%
- Stomatitis (inflammation of mucous membrane of mouth): 2 people, 18.18%
- Hepatic Function Abnormal: 2 people, 18.18%
- Rashes (redness): 2 people, 18.18%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Appetite - decreased?
- Check whether Appetite - decreased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Malignant pleural effusion (2,452 reports)
- Appetite - decreased (264,653 reports)
All the drugs that are associated with Appetite - decreased:
- Appetite - decreased (3,554 drugs)
All the conditions that are associated with Appetite - decreased:
- Appetite - decreased (4,589 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Appetite - decreased and Malignant pleural effusion, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Otezla and Vigamox - 5 seconds ago
- Drug interactions of Meropenem and Raltegravir - 7 seconds ago
- Drug interactions of Losartan and Bisacodyl - 18 seconds ago
- Could Rabeprazole Sodium cause Spinal Pain? - 21 seconds ago
- Could Zide cause Folliculitis? - 45 seconds ago
- Could Apresoline cause Coronary Heart Disease? - a minute ago
- Could Cleocin T cause Fainting? - a minute ago
- Duragesic-100 vs. Prozac, side effect and effectiveness comparison - a minute ago
- Weight Loss and Otitis - a minute ago
- Could Kemadrin cause Movement - Uncontrolled Or Slow? - a minute ago